---
title: ProRelix Research vs SMO India Clinical Research Pvt Ltd
slug_a: prorelixresearch
slug_b: smo-india
site: cro
review_signal_gate: closed
canonical_path: /compare/prorelixresearch/smo-india
generated_by: BioBM Editorial AI
---

# ProRelix Research vs SMO India Clinical Research Pvt Ltd

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

ProRelix Research (prorelixresearch) is listed for cro. ProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia.

Services: 9. Modalities: 0. Indications: 0. Locations: 4. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

SMO India Clinical Research Pvt Ltd (smo-india) is listed for cro. CDSCO-registered CRO with 25+ years of clinical trial experience across Phase I–IV studies in India. Specializes in site management, clinical operations, and regulatory affairs across diverse therapeutic areas.

Services: 6. Modalities: 0. Indications: 0. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.